National Health (Price and Special Patient Contribution) Amendment Determination 2019 (No. 7) (PB 65 of 2019) (Cth)
PB 65 of 2019
National Health (Price and Special Patient Contribution) Amendment Determination 2019 (No. 7)
National Health Act 1953
___________________________________________________________________________
I, THEA DANIEL, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Determination under section 85B of the National Health Act 1953.
Dated 26 July 2019
THEA DANIEL
Assistant Secretary
Pricing and PBS Policy Branch
Technology Assessment and Access Division
Department of Health
_________________________________________________________________________
Name of Instrument
(1)This Instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2019 (No. 7).
(2)This Instrument may also be cited as PB 65 of 2019.
Commencement
This Instrument commences on 1 August 2019.
Amendment of National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)
Schedule 1 amends the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010).
Schedule 1 Amendments
Schedule 1, entry for Atenolol
omit from the column headed “Claimed Price”: 7.33 substitute: 13.58
Schedule 1, entry for Candesartan in the form Tablet containing candesartan cilexetil 4 mg
omit from the column headed “Claimed Price”: 6.65 substitute: 12.96
Schedule 1, entry for Candesartan in the form Tablet containing candesartan cilexetil 8 mg
omit from the column headed “Claimed Price”: 7.52 substitute: 13.82
Schedule 1, entry for Candesartan in the form Tablet containing candesartan cilexetil 16 mg
omit from the column headed “Claimed Price”: 10.06 substitute: 16.37
Schedule 1, entry for Candesartan in the form Tablet containing candesartan cilexetil 32 mg
omit from the column headed “Claimed Price”: 13.62 substitute: 17.17
Schedule 1, entry for Candesartan with Hydrochlorothiazide in the form Tablet containing candesartan cilexetil 16 mg with hydrochlorothiazide 12.5 mg
omit from the column headed “Claimed Price”: 10.34 substitute: 16.65
Schedule 1, entry for Candesartan with Hydrochlorothiazide in the form Tablet containing candesartan cilexetil 32 mg with hydrochlorothiazide 12.5 mg
omit from the column headed “Claimed Price”: 15.40 substitute: 17.35
Schedule 1, entry for Candesartan with Hydrochlorothiazide in the form Tablet containing candesartan cilexetil 32 mg with hydrochlorothiazide 25 mg
omit from the column headed “Claimed Price”: 15.76 substitute: 18.12
Schedule 1, entry for Citalopram
omit from the column headed “Claimed Price”: 9.65 substitute: 11.15
[10] Schedule 1, entry for Erythromycin
omit:
| Oral | E.E.S. 200 | 1 | 4.46 | 6.66 | |
| Powder for oral liquid 400 mg (as ethyl succinate) per 5 mL, 100 mL | Oral | E.E.S. Granules | 1 | 5.68 | 7.90 |
[11] Schedule 1, entry for Escitalopram in the form Tablet 10 mg (as oxalate)
omit from the column headed “Claimed Price”: 11.35 substitute: 12.85
[12] Schedule 1, entry for Escitalopram in the form Tablet 20 mg (as oxalate)
omit from the column headed “Claimed Price”: 11.69 substitute: 13.19
[13] Schedule 1, entry for Hypromellose
omit:
| Application to the eye | Genteal | 1 | 3.12 | 7.15 |
[14] Schedule 1, entry for Ibuprofen
omit from the column headed “Claimed Price”: 4.11 substitute: 4.58
[15] Schedule 1, entry for Lisinopril in the form Tablet 5 mg
omit from the column headed “Claimed Price”: 5.51 substitute: 6.51
[16] Schedule 1, entry for Lisinopril in the form Tablet 10 mg
omit from the column headed “Claimed Price”: 6.51 substitute: 7.51
[17] Schedule 1, entry for Lisinopril in the form Tablet 20 mg
omit from the column headed “Claimed Price”: 7.29 substitute: 8.29
[18] Schedule 1, entry for Metoprolol in the form Tablet containing metoprolol tartrate 50 mg [Brand: Betaloc]
omit from the column headed “Claimed Price”: 5.26 substitute: 9.66
[19] Schedule 1, entry for Metoprolol in the form Tablet containing metoprolol tartrate 100 mg
omit from the column headed “Claimed Price”: 5.76 substitute: 10.16
[20] Schedule 1, entry for Olmesartan in the form Tablet containing olmesartan medoxomil 20 mg
omit from the column headed “Claimed Price”: 6.85 substitute: 7.60
[21] Schedule 1, entry for Olmesartan in the form Tablet containing olmesartan medoxomil 40 mg
omit from the column headed “Claimed Price”: 11.73 substitute: 12.46
[22] Schedule 1, entry for Olmesartan in the form Tablet containing olmesartan medoxomil 20 mg with hydrochlorothiazide 12.5 mg
omit from the column headed “Claimed Price”: 7.26 substitute: 7.61
[23] Schedule 1, entry for Olmesartan in the form Tablet containing olmesartan medoxomil 40 mg with hydrochlorothiazide 12.5 mg
omit from the column headed “Claimed Price”: 12.13 substitute: 12.51
[24] Schedule 1, entry for Olmesartan in the form Tablet containing olmesartan medoxomil 40 mg with hydrochlorothiazide 25 mg
omit from the column headed “Claimed Price”: 13.55 substitute: 13.90
[25] Schedule 1, omit entry for Potassium chloride
[26] Schedule 1, entry for Propranolol in the form Tablet containing propranolol hydrochloride 10 mg [Brand: Inderal]
omit from the column headed “Claimed Price”: 6.05 substitute: 10.45
[27] Schedule 1, entry for Propranolol in the form Tablet containing propranolol hydrochloride 40 mg [Brand: Inderal]
omit from the column headed “Claimed Price”: 6.30 substitute: 10.70
[28] Schedule 1, entry for Salbutamol in the form Pressurised inhalation 100 micrograms (as sulfate) per dose, 200 doses (CFC-free formulation)
omit from the column headed “Claimed Price”: 5.10 substitute: 5.60
0
0
0